)
Walgreens Boots Alliance (WBA) investor relations material
Walgreens Boots Alliance Proxy Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Entered into a Merger Agreement on March 6, 2025, with Blazing Star Parent, LLC, to take the company private, with a shareholder vote scheduled for July 11, 2025.
Supplemental proxy disclosures address shareholder litigation and demand letters alleging insufficient or misleading information in the original proxy statement.
Forward-looking statements highlight risks related to transaction completion, regulatory approvals, financing, and potential litigation.
Voting matters and shareholder proposals
Shareholders are to vote on the adoption of the Merger Agreement at a special meeting.
Litigation seeks to enjoin the shareholder vote pending additional disclosures.
Board of directors and corporate governance
Board reviewed multiple acquisition proposals, confidentiality agreements, and the role of key stakeholders, including potential equity rollovers.
Board considered potential conflicts of interest and received relationship disclosures from financial advisors and legal counsel.
- All board proposals passed, losses reviewed, and a multi-year turnaround plan was detailed.WBA
AGM 2025 - Shareholders to receive $11.45 cash plus up to $3.00 per share from asset sale in take-private merger.WBA
Proxy Filing - Shareholders to vote on $11.45 cash merger plus contingent DAP Rights; board recommends approval.WBA
Proxy Filing - Shareholders to vote on a $11.45 per share cash-out merger with contingent DAP Rights.WBA
Proxy Filing - Shareholders to vote on board, compensation, incentive plans, auditor, and ESG matters.WBA
Proxy Filing - Proxy covers board elections, executive pay, equity plans, auditor, ESG, and risk oversight.WBA
Proxy Filing - Sales up 6.2% to $147.7B, but net loss surged on impairments; 1,200 store closures planned.WBA
Q4 2024 - Decentralized clinical trials and diverse patient recruitment drive growth in pharmacy-led research.WBA
TD Cowen 9th Annual FutureHealth Conference - Adjusted EPS down 36.6% and $12.4B impairment drove a $5.6B loss; 2024 guidance cut.WBA
Q3 2024 - Sales up 7.5% to $39.5B, but net loss widened on restructuring and retail headwinds.WBA
Q1 2025
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
Frequently asked questions
An Alliance of Pharmacies
Walgreens Boots Alliance, popularly known as Walgreens or Boots depending on the country. The company has an expansive array of offerings that range from prescriptions and over-the-counter medications to beauty products and health services. The company owns a multitude of brands, with Walgreens and Boots being the most prominent in its portfolio. Walgreens, a staple in the American pharmacy landscape, operates thousands of stores across the U.S. On the other hand, Boots, with its deep-rooted British heritage, dominates the UK and Ireland while also having a presence in other parts of the world.
Historical Foundations
Walgreens was founded by Charles R. Walgreen, who opened the first Walgreens drugstore in Chicago during the early 1900s. What began as a small neighborhood pharmacy gradually expanded into a network of stores across the USA. Simultaneously, on the other side of the Atlantic, the Boots brand was evolving in the UK, founded by John Boot. The merging of these two resulted in the formation of the Walgreens Boots Alliance in 2014. Today, the company has a sprawling presence, with over 18,000 stores in 11 countries. Boots is by far the largest pharmacy chain in the UK, while Walgreens together with CVS dominates the American market.
Pharmacy Services
Central to Walgreens Boots Alliance's appeal is its comprehensive portfolio of health and beauty services. Customers can not only fulfill their prescriptions but also access services like health tests, vaccinations, and specialized advice on medications and general well-being. Moreover, with an extensive range of beauty and personal care products, the stores offer an amalgamation of health and beauty, making them a preferred choice for consumers. The company has also moved with the times by utilizing technology. From online prescription refills to telehealth services and a user-friendly mobile app, the brand has ensured convenient and accessible services and shopping.
No7 Beauty
No7 Beauty is a skincare and cosmetics brand owned by the company. It was founded in 1935 by Boots and was a pioneer in offering affordable products without cutting down on quality. Today, this is a global brand sold across the world and not only in its parent companies' retail locations.
)